First PI3K Inhibitor Approved for Metastatic, Advanced Breast Cancer

Piqray approved for HR-positive, HER2-negative, PIK3CA-mutated, metastatic or advanced breast cancer
Source: Cancercompass News: Breast Cancer - Category: Cancer & Oncology Source Type: news